Home » Topics » Regulatory

Regulatory
RSS

Arava approved in Europe for active psoriatic arthritis

July 2, 2004

Change of indications for phase II trials of KOS-862

June 29, 2004

Biovail's NDA for novel dosage form of citalopram accepted for review

June 16, 2004

FDA approves Vidaza for treatment of MDS

May 24, 2004

FDA approves DepoDur for treatment of pain

May 21, 2004

New approval for Enbrel in psoriasis

May 5, 2004

New indication and strength approved for Hectorol

April 29, 2004

FDA approval for ChiRhoClin's human secretin

April 16, 2004

European approval sought for candesartan cilexetil for chronic heart failure

April 14, 2004

MediGene extends clinical development of Polyphenon E to actinic keratosis

April 13, 2004